| Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Patent applications |
| Patent application number | Title | Published |
|---|
| 20110305757 | NEW PHARMACEUTICAL COMBINATIONS - A pharmaceutical composition including a compound of Formula I (Compound I) or pharmaceutically acceptable salts thereof and one or more diuretics as effective components, wherein said one or more diuretics are selected from thiazide derivatives. Methods for preparing the pharmaceutical compound including Compound I and thiazide derivatives and its use for preventing or treating hypertension in mammals, particularly in humans. | 12-15-2011 |
| 20110274753 | DUAL RELEASE ORAL TABLET COMPOSITIONS OF DEXLANSOPRAZOLE - Dual release oral tablet compositions of dexlansoprazole or pharmaceutically acceptable salts or hydrated forms thereof and processes for the manufacture of the tablet composition and its use in the treatment of gastrointestinal disorders. | 11-10-2011 |
| 20110274751 | TRIMETAZIDINE FORMULATION WITH DIFFERENT RELEASE PROFILES - A multilayered solid oral pharmaceutical formulation of trimetazidine or a pharmaceutically acceptable salt or polymorph of trimetazidine wherein one layer of said formulation provides controlled release, while the other layer provides immediate release. | 11-10-2011 |
| 20110257159 | ORALLY DISINTEGRATING TABLET FORMULATIONS OF MIRTAZAPINE AND PROCESS FOR PREPARING THE SAME - Silicon dioxide free orally disintegrating tablet formulations of mirtazapine or a pharmaceutically acceptable salt thereof having crospovidone and sodium stearyl fumarate and one or more pharmaceutically acceptable excipients and a process for preparing such a formulation. | 10-20-2011 |
| 20110236473 | STABLE ALISKIREN FORMULATIONS - An oral pharmaceutical formulation, made up of croscarmellose sodium and internal granules including a pharmaceutically acceptable salt or polymorph of aliskiren and stearic acid. | 09-29-2011 |
| 20110071098 | FLURBIPROFEN AND MUSCLE RELAXANT GEL COMBINATIONS THEREOF - A topical pharmaceutical gel includes flurbiprofen or a pharmaceutically acceptable salt of flurbiprofen, thiocolchicoside or a pharmaceutically acceptable salt of thiocolchicoside, and menthol. Pharmaceutical combinations of flurbiprofen, thiocolchicoside, and menthol in the form of topical gels with anti-inflammatory, analgesic, and myorelaxant activities are described. | 03-24-2011 |
| 20110053877 | NIMESULIDE AND MUSCLE RELAXANT COMBINATIONS THEREOF - A topical pharmaceutical formulation made up of nimesulide or a pharmaceutically acceptable derivative of nimesulide, together with thiocolchicoside or a pharmaceutically acceptable derivative of thiocolchicoside. The present invention more particularly relates to pharmaceutical combinations of nimesulide and thiocolchicoside, in the form of topical gels, ointments, cream, sprays, or lotions with anti-inflammatory, analgesic, and myorelaxant activities. | 03-03-2011 |
| 20110020445 | EXTENDED RELEASE PHARMACEUTICAL COMPOSITIONS OF LEVETIRACETAM - Extended release pharmaceutical compositions of levetiracetam or pharmaceutically acceptable salts thereof in the form of a tablet comprising glyceryl behenate and a polymethacrylate polymer with at least one pharmaceutically acceptable excipient. | 01-27-2011 |
| 20100272800 | ORALLY DISINTEGRATING OLANZAPINE TABLET - According to the present invention an orally disintegrating olanzapine tablet comprising magnesium stearate and sodium stearyl fumarate and one or more phramaceutically acceptable excipient in which the total weight of magnesium stearate and sodium stearyl fumarate is about 0.1 to 5% by weight of the total tablet and wherein the tablet disintegrates within up to 90 seconds in oral cavity is provided. | 10-28-2010 |
| 20100234342 | EZETIMIBE COMPOSITIONS - This invention is a novel pharmaceutical composition of ezetimibe or a pharmaceutically acceptable salt thereof comprising one or more pharmaceutically acceptable excipients having high bioavailability with improved solubility and dissolution rate which is stable throughout the shelflife, methods for their preparation, and methods for treatment using the same. | 09-16-2010 |
